Conclusion Combined rosiglitazone and clomiphene was an effective therapeutic regimen for correcting insulin resistance in patients with PCOS possibly by reducing IGF1 bioavailability to the ovaries thus modifying the hyperandrogenic intrafollicular milieu that occurs in PCOS priligy review
Conclusion Combined rosiglitazone and clomiphene was an effective therapeutic regimen for correcting insulin resistance in patients with PCOS possibly by reducing IGF1 bioavailability to the ovaries thus modifying the hyperandrogenic intrafollicular milieu that occurs in PCOS priligy review